Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Temozolomide in Metastatic Melanoma
NCT00811759Phase 2Unknown
- Sponsor
- Gustave Roussy
- Start
- Jun 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in melanoma, sponsored by Gustave Roussy. Status: unknown.
02
Drugs
sorafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00811759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811759.